USD 80.71
(-1.1%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 5.14 Billion USD | -6.66% |
2022 | 5.51 Billion USD | -10.94% |
2021 | 6.18 Billion USD | 15.04% |
2020 | 5.37 Billion USD | 10.27% |
2019 | 4.87 Billion USD | -31.29% |
2018 | 7.09 Billion USD | 6.82% |
2017 | 6.64 Billion USD | 1.13% |
2016 | 6.57 Billion USD | 7.51% |
2015 | 6.11 Billion USD | 22.95% |
2014 | 4.97 Billion USD | 3.69% |
2013 | 4.79 Billion USD | 0.44% |
2012 | 4.77 Billion USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 1.27 Billion USD | -16.31% |
2023 Q1 | 1.32 Billion USD | -22.49% |
2023 Q2 | 1.51 Billion USD | 14.39% |
2023 Q3 | 1.44 Billion USD | -4.17% |
2023 Q4 | 1.52 Billion USD | 5.53% |
2023 FY | 5.73 Billion USD | 4.01% |
2022 Q3 | 1.27 Billion USD | -7.15% |
2022 Q4 | 1.7 Billion USD | 33.78% |
2022 Q1 | 1.07 Billion USD | -37.41% |
2022 Q2 | 1.37 Billion USD | 28.01% |
2022 FY | 5.51 Billion USD | -10.94% |
2021 Q1 | 978 Million USD | -47.5% |
2021 FY | 6.18 Billion USD | 15.04% |
2021 Q2 | 1.65 Billion USD | 69.53% |
2021 Q3 | 1.78 Billion USD | 7.6% |
2021 Q4 | 1.71 Billion USD | -4.09% |
2020 Q2 | 1.17 Billion USD | 74.44% |
2020 FY | 5.37 Billion USD | 10.27% |
2020 Q1 | 673 Million USD | 99.7% |
2020 Q3 | 1.62 Billion USD | 38.76% |
2020 Q4 | 1.86 Billion USD | 14.36% |
2019 Q2 | 1.54 Billion USD | -4.7% |
2019 FY | 4.87 Billion USD | -31.29% |
2019 Q4 | 337 Million USD | -81.07% |
2019 Q3 | 1.78 Billion USD | 15.58% |
2019 Q1 | 1.61 Billion USD | -23.56% |
2018 Q2 | 1.54 Billion USD | 9.03% |
2018 Q4 | 2.11 Billion USD | 24.72% |
2018 Q3 | 1.69 Billion USD | 9.71% |
2018 Q1 | 1.41 Billion USD | -34.52% |
2018 FY | 7.09 Billion USD | 6.82% |
2017 Q1 | 1.45 Billion USD | -18.42% |
2017 FY | 6.64 Billion USD | 1.13% |
2017 Q3 | 1.78 Billion USD | 37.45% |
2017 Q4 | 2.16 Billion USD | 21.57% |
2017 Q2 | 1.29 Billion USD | -10.87% |
2016 Q1 | 1.39 Billion USD | -24.45% |
2016 FY | 6.57 Billion USD | 7.51% |
2016 Q4 | 1.78 Billion USD | 24.89% |
2016 Q3 | 1.42 Billion USD | -5.69% |
2016 Q2 | 1.51 Billion USD | 8.23% |
2015 Q3 | 1.3 Billion USD | -4.19% |
2015 FY | 6.11 Billion USD | 22.95% |
2015 Q1 | 1.41 Billion USD | -4.08% |
2015 Q2 | 1.36 Billion USD | -3.54% |
2015 Q4 | 1.84 Billion USD | 41.69% |
2014 Q2 | 1.19 Billion USD | 0.84% |
2014 FY | 4.97 Billion USD | 3.69% |
2014 Q4 | 1.47 Billion USD | 26.46% |
2014 Q3 | 1.16 Billion USD | -2.92% |
2014 Q1 | 1.18 Billion USD | -14.77% |
2013 Q4 | 1.39 Billion USD | 20.26% |
2013 Q2 | 1.15 Billion USD | 1.85% |
2013 Q1 | 1.13 Billion USD | -15.84% |
2013 Q3 | 1.16 Billion USD | 0.17% |
2013 FY | 4.79 Billion USD | 0.44% |
2012 Q4 | 1.35 Billion USD | 19.14% |
2012 FY | 4.77 Billion USD | 0.0% |
2012 Q3 | 1.13 Billion USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Phreesia, Inc. | -131.77 Million USD | 4003.683% |
Accuray Incorporated | 504 Thousand USD | -1020534.921% |
Align Technology, Inc. | 643.33 Million USD | -699.58% |
Elevance Health Inc. | 133.96 Billion USD | 96.16% |
AxoGen, Inc. | -21.46 Million USD | 24067.943% |
Boston Scientific Corporation | 2.34 Billion USD | -119.548% |
CVS Health Corporation | 13.74 Billion USD | 62.57% |
Cardinal Health, Inc. | 1.24 Billion USD | -313.837% |
Centene Corporation | 2.93 Billion USD | -75.563% |
DaVita Inc. | 1.6 Billion USD | -220.942% |
HCA Healthcare, Inc. | 9.62 Billion USD | 46.567% |
Hologic, Inc. | 970.2 Million USD | -430.2% |
Humana Inc. | 4.01 Billion USD | -28.183% |
IDEXX Laboratories, Inc. | 1.09 Billion USD | -368.861% |
Laboratory Corporation of America Holdings | 725.6 Million USD | -608.931% |
Masimo Corporation | 136.5 Million USD | -3668.498% |
McKesson Corporation | 3.9 Billion USD | -31.594% |
Patterson Companies, Inc. | 252.92 Million USD | -1933.813% |
Quest Diagnostics Incorporated | 1.26 Billion USD | -307.607% |
ResMed Inc. | 1.31 Billion USD | -289.729% |
Henry Schein, Inc. | 615 Million USD | -736.423% |
Teladoc Health, Inc. | -248.55 Million USD | 2169.579% |
Universal Health Services, Inc. | 1.17 Billion USD | -337.645% |
Veeva Systems Inc. | 429.33 Million USD | -1098.135% |
Baxter International Inc. | 390 Million USD | -1218.974% |
Becton, Dickinson and Company | 2.11 Billion USD | -143.676% |
Intuitive Surgical, Inc. | 1.76 Billion USD | -191.148% |
Danaher Corporation | 5.38 Billion USD | 4.404% |
Stryker Corporation | 3.88 Billion USD | -32.305% |